Intellectual property organizations

Tauriga Sciences Inc. to Resume the Clinical Development of its Proposed “Anti-Nausea” Pharmaceutical Grade Version of Tauri-Gum

Retrieved on: 
Wednesday, December 16, 2020

The Company expects to issue a material update to shareholders, within the near term (concerning the resumption of this Pharmaceutical Development Work).

Key Points: 
  • The Company expects to issue a material update to shareholders, within the near term (concerning the resumption of this Pharmaceutical Development Work).
  • The delivery system for this proposed Pharmaceutical version is a modified version (substantially higher concentration of CBD) of the existing Tauri-Gum chewing gum formulation based on continued research and development.
  • On March 18, 2020 the Company announced that it had filed a Provisional U.S. Patent covering its Pharmaceutical grade version of Tauri-Gum.This patent application, filed with the United States Patent & Trademark Office (U.S.P.T.O.
  • Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances.

Nutriband Inc. Receives Notice of Allowance from Korean Intellectual Property Office (KIPO) for its 'Abuse and Misuse Deterrent Transdermal System' Patent

Retrieved on: 
Thursday, December 10, 2020

ORLANDO, Fla., Dec. 10, 2020 /PRNewswire/ --Nutriband Inc. (OTCQB: NTRB), a Nevada corporation (the "Company") has received a notice of allowance from the Korean Intellectual Property Office (KIPO) for the 'Abuse and Misuse Deterrent Transdermal Systems' patent application filed by its clinical subsidiary 4P Therapeutics.

Key Points: 
  • ORLANDO, Fla., Dec. 10, 2020 /PRNewswire/ --Nutriband Inc. (OTCQB: NTRB), a Nevada corporation (the "Company") has received a notice of allowance from the Korean Intellectual Property Office (KIPO) for the 'Abuse and Misuse Deterrent Transdermal Systems' patent application filed by its clinical subsidiary 4P Therapeutics.
  • The patent underpins 4p Therapeutics' abuse deterrent fentanyl transdermal system, AVERSA, which uses Taste aversion to addresses the primary routes of abuse for opioid based transdermal patches.
  • The Korean Intellectual Property Office is the latest to approve or allow the patent application following similar outcomes in Mexico, Europe, Russia, Australia and Japan.
  • The Company is primarily engaged in the development of a portfolio of transdermal pharmaceutical products.

Fortay Awarded U.S. Patent for Culture Determination Engine Designed to Help Companies Build Diverse Aligned Teams

Retrieved on: 
Thursday, December 10, 2020

TORONTO, Dec. 10, 2020 /PRNewswire-PRWeb/ --Fortay announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No.

Key Points: 
  • TORONTO, Dec. 10, 2020 /PRNewswire-PRWeb/ --Fortay announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No.
  • Fortay's Culture Add Hiring solution is powered by this patented technology - designed to address challenges in today's world of talent acquisition.
  • With Fortay, organizations build diverse values-aligned teams in a way that reduces bias and increases diversity, fairness, and overall hiring efficiency.
  • Fortay.ai is a leading enterprise team success platform that helps forward-thinking organizations build diverse aligned teams and healthy inclusive workplace cultures for organizational success.

Call for expression of interest: Alternate Chairperson of the Board of Appeal of the CPVO

Retrieved on: 
Wednesday, December 9, 2020

In those situations, the Alternate Chairperson shall:select for each case the other members of the Board of Appeal and their respective alternates from a list of qualified members established by the Administrative Council of the Office,head the Board of Appeal of the Office and exercise the powers vested in the Chairperson by Regulation (EC) No 2100/94.REQUIREMENTSThe candidate must be a national of one of the EU Member States.The candidate shall not perform any other duties in the Community Plant Variety Office.The candidate must have a very good knowledge of English (3). Knowledge of other official EU languages is an advantage.The candidate must also have:A university degree in law, or a qualification by recognised experience in the field of intellectual property or plant variety registrationAt least 10 years of post-graduate level work experience (4) of which a significant part relates to intellectual property; plant variety rights would be an advantage.Judicial or related experience in the field of intellectual property would be an advantage, as also administrative and management experience, preferably acquired in the public service of a Member State or of an intergovernmental organisation.The remuneration of the Alternate Chairperson the Board of Appeal who is not an EU servant is as follows:Remuneration per actual day of work (1 day/8 hours): 500 (in EUR),Maximum remuneration per one appeal: 7 500 (in EUR).The Board of Appeal consist of a Chairperson, two other members, and their respective alternates.

Key Points: 
  • In those situations, the Alternate Chairperson shall:
    • select for each case the other members of the Board of Appeal and their respective alternates from a list of qualified members established by the Administrative Council of the Office,
    • head the Board of Appeal of the Office and exercise the powers vested in the Chairperson by Regulation (EC) No 2100/94.
  • REQUIREMENTS
    • The candidate must be a national of one of the EU Member States.
    • The candidate shall not perform any other duties in the Community Plant Variety Office.
    • The candidate must have a very good knowledge of English (3). Knowledge of other official EU languages is an advantage.
    • The candidate must also have:
    • A university degree in law, or a qualification by recognised experience in the field of intellectual property or plant variety registration
    • At least 10 years of post-graduate level work experience (4) of which a significant part relates to intellectual property; plant variety rights would be an advantage.
    • Judicial or related experience in the field of intellectual property would be an advantage, as also administrative and management experience, preferably acquired in the public service of a Member State or of an intergovernmental organisation.
  • The remuneration of the Alternate Chairperson the Board of Appeal who is not an EU servant is as follows:
    • Remuneration per actual day of work (1 day/8 hours): 500 (in EUR),
    • Maximum remuneration per one appeal: 7 500 (in EUR).
    • The Board of Appeal consist of a Chairperson, two other members, and their respective alternates.
    • Where the Board of Appeal considers that the nature of the appeal so requires, it may call up to two further members.
    • DESCRIPTION OF THE FUNCTIONS The CPVO is looking for an Alternate Chairperson of the Board of Appeal of the Office.
    • In the absence of the Chairperson, his/ her alternate shall perform the tasks of the Chairperson.
    • The Alternate Chairperson of the Board of Appeal shall be independent.
    • More information on the Board of Appeal can be found at: http://cpvo.europa.eu/main/en/home/community-plant-variety-rights/board-... APPOINTMENT The current term of office of the Alternate Chairperson of the Board of Appeal runs until 14October 2021.
    • The purpose of this call for expression of interest is to allow the Commission to draw up a shortlist of candidates for the function of Alternate Chairperson of the Board of Appeal, which it will submit to the Council.
    • CONDITIONS OF EMPLOYMENT In the absence of the Chairperson, the Alternate Chairperson will be expected to be available on a part-time basis, to deal with appeal cases as they arise.
    • The Alternate Chairperson will be required to declare any interests, which may conflict with his/ her duty to the Board of Appeal.
    • To this end, it is appropriate that the assignment to serve on the CPVO Board of Appeal as Alternate Chairperson is agreed with their EU Institution or Agency.
    • Hearings of the Board of Appeal are held at the seat of the CPVO in Angers, France, or virtually.

    Subscribe to CPVO Newsletter

  • CGE Energy Granted Sixth Patent for Innovative Wind Turbine

    Retrieved on: 
    Tuesday, November 24, 2020

    ( OTCPink: CGEI ) is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.

    Key Points: 
    • ( OTCPink: CGEI ) is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.
    • The issuance of this sixth patent enhances the strength of our intellectual property protection around our vertical axis wind turbine, saidBryan Zaplitny, President and CEO ofCGE Energy.
    • To date, CGE Energy has received five U.S. patents as well as one European patent for the technology.
    • CGE Energy, Inc. , and its wholly-owned subsidiary Clean Green Energy, Inc., is a developer of long-term energy projects and self-powered infrastructure which solve the unique energy challenges of their commercial, municipal and nonprofit customers.

    IPR Center, Amazon Launch ‘Operation Fulfilled Action’ to Stop Counterfeits

    Retrieved on: 
    Tuesday, November 24, 2020

    The U.S. governments National Intellectual Property Rights Coordination Center (IPR Center) and Amazon today announced the launch of a joint operation to prevent counterfeit goods from entering the U.S. and help protect American consumers.

    Key Points: 
    • The U.S. governments National Intellectual Property Rights Coordination Center (IPR Center) and Amazon today announced the launch of a joint operation to prevent counterfeit goods from entering the U.S. and help protect American consumers.
    • Now, by combining intelligence from Amazon, the IPR Center, and other agencies, were able to stop counterfeits at the border, regardless of where bad actors were intending to offer them.
    • The IPR Center and Amazon will leverage evidence obtained during the operation to expand on-going investigations, with the goal of holding bad actors accountable to the fullest extent of the law.
    • Amazon proactively provides the IPR Center with data on confirmed counterfeiters to assist with investigative efforts to stop crime.

    Ingevity to challenge U.S. court ruling on emission control patent and expects limited impact on commercial operations or financial results through patent expiration in March 2022

    Retrieved on: 
    Wednesday, November 18, 2020

    Ingevity is the established technology leader in providing world-leading products for use in automotive evaporative emissions control systems.

    Key Points: 
    • Ingevity is the established technology leader in providing world-leading products for use in automotive evaporative emissions control systems.
    • The patent has twice been upheld by the U.S. Patent and Trademark Office, and, put simply, said Woodcock, we want our day in court.
    • Woodcock also stated that Ingevity expects limited impact on its commercial operations or financial results through patent expiration in March 2022 specifically as a result of yesterdays decision.
    • Ingevity assumes no obligation to provide any revisions to, or update, any projections and forward-looking statements contained in this press release.

    New Reports Offer Insight into the Future of Intellectual Property

    Retrieved on: 
    Tuesday, November 17, 2020

    NEW YORK, Nov. 17, 2020 /PRNewswire-PRWeb/ --What does the future of intellectual property (IP) look like?

    Key Points: 
    • NEW YORK, Nov. 17, 2020 /PRNewswire-PRWeb/ --What does the future of intellectual property (IP) look like?
    • It has highlighted the vital importance of preparing for the future."
    • For IPOs, the "Report: The Intellectual Property Office (IPO) of the Future " concludes: "With so much change occurring simultaneously, we must ensure that IPOs of the future are nimble and robust enough to absorb, manage, facilitate, and enable change."
    • The experts explore three key themes: the evolution of the IP system, future challenges and opportunities, and the key features that an IPO of the future should have.

    TrustyIP receives Gold Special Award from the 4th World Invention Academic Conference (WIAC 2020)

    Retrieved on: 
    Wednesday, November 11, 2020

    ZEPHYR COVE, Nev., Nov.11, 2020 /PRNewswire-PRWeb/ -- TrustyIP announced today that it received the Gold Special Award in the 4th World Invention Academic Conference (WIAC 2020) by the WIAC organizing committee and Korea Invention News (KINEWS), the leading international awards organization honoring excellence on international inventions.

    Key Points: 
    • ZEPHYR COVE, Nev., Nov.11, 2020 /PRNewswire-PRWeb/ -- TrustyIP announced today that it received the Gold Special Award in the 4th World Invention Academic Conference (WIAC 2020) by the WIAC organizing committee and Korea Invention News (KINEWS), the leading international awards organization honoring excellence on international inventions.
    • Mr. Soung-Mo Hong, President of KINEWS, congratulated TrustyIP on the results of the review and evaluation.
    • The USPTO's First-To-File system grants patent rights to those who swiftly file regardless of the invention or conception date.
    • "We designed TrustyIP to address roadblock issues that prevent you or your team from protecting your intellectual properties from our experience writing and prosecuting patent applications.

    Notice of Allowance issued for one of several pending patent applications for the SixFix® Circular Fixator

    Retrieved on: 
    Friday, November 6, 2020

    COLLIERVILLE, Tenn., Nov. 6, 2020 /PRNewswire/ --AMDT Holdings, Inc. is pleased to announce the recent issuance of a Notice of Allowance from the United States Patent and Trademark Office for one of its several pending patent applications on its SixFix Circular Fixator.When this patent issues it will join a growing portfolio of other AMDT US and foreign patents that protect the SixFix Circular Fixator, the SixFix Deformity Analysis and Correction Software and the AMDT Mini-Rail Fixator System.

    Key Points: 
    • COLLIERVILLE, Tenn., Nov. 6, 2020 /PRNewswire/ --AMDT Holdings, Inc. is pleased to announce the recent issuance of a Notice of Allowance from the United States Patent and Trademark Office for one of its several pending patent applications on its SixFix Circular Fixator.When this patent issues it will join a growing portfolio of other AMDT US and foreign patents that protect the SixFix Circular Fixator, the SixFix Deformity Analysis and Correction Software and the AMDT Mini-Rail Fixator System.
    • AMDT Holdings continues to aggressively add to its stable of pending US and foreign patent applications to expand its protective reach as new commercial developments supplement its family of External Fixation products.
    • To learn more about AMDT and our technologies, please visit www.AMDTHoldings.com .